Common Contracts

1 similar License and Joint Development Agreement contracts

License and Joint Development Agreement on Novel Biliary Tract Cancer Treatment
License and Joint Development Agreement • April 24th, 2019

Ohara Pharmaceutical Co., Ltd. (Head office: Shiga, Japan; CEO: Seiji Ohara; hereinafter, “Ohara”) has entered into a license and joint development agreement with J-Pharma Co., Ltd, dated April 25, 2019 regarding the novel compound JPH203. (Head office: Kanagawa, Japan; Representative Director and Chairman: Hitoshi Endou, M.D., Ph.D; Representative Director and President: Masuhiro Yoshitake; hereinafter, “J-Pharma”).

AutoNDA by SimpleDocs
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!